Universal Cancer Technologies - Accelerating Cancer Detection

Accelerating Cancer Detection

ASCO 2024: ‘CA-62: A new biomarker for the detection of early-stage renal carcinoma’ posterpresentation.

23

Jul

July 23, 2024

News

ASCO 2024: ‘CA-62: A new biomarker for the detection of early-stage renal carcinoma’ posterpresentation.

ASCO® 2024 Insights: “CA-62 – A New Biomarker for the Detection of Early Stage RCC”
https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.4526